Straumann Stock - Analyst consensus and valuation snapshot
21.06.2026 - 07:39:34 | ad-hoc-news.de
Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 07:38 CET. Details in the imprint.
Straumann (CH0012280076) remains a core name in European medical technology as investors track earnings momentum and valuation. Analyst consensus and recent guidance provide a structured view on expected growth, margins and cash generation, according to current broker data.
All news and key figures on Straumann stock
Background pieces, company releases and market data on Straumann are bundled on the dedicated topic page and the group's Investor Relations site.
What analysts currently expect
Straumann is followed by a broad group of European and global brokers, with consensus data compiled by platforms such as MarketScreener and major banks. Recent estimates indicate solid double-digit sales growth over the next two years, alongside gradual margin expansion.
On the earnings side, consensus points to continued recovery after the pandemic years, helped by robust demand for premium dental implants and clear-aligner solutions. Reported comments from management have underlined attractive structural trends in aesthetic dentistry and emerging markets.
Valuation and peer comparison
On traditional valuation metrics, Straumann typically trades at a premium to many diversified medtech peers, reflecting its focused business model and high margins. Investors therefore pay close attention to growth delivery relative to expectations when assessing upside and downside.
Compared with selected dental peers, the stock's multiples mirror strong profitability and a clear focus on implantology and orthodontics. At the same time, sector rotation and interest-rate expectations can influence how much of that quality premium the market is willing to support at any given moment.
How Straumann earns its money
Straumann generates most of its revenue from dental implants, biomaterials, digital dentistry equipment and clear-aligner systems used by dentists and orthodontists worldwide. The group combines premium implant lines with value brands and services to address a broad range of patient budgets.
Where the stock trades today
The shares of Straumann (CH0012280076) trade on SIX Swiss Exchange in Swiss francs; the latest available quote and market capitalization can be found on the exchange's official data pages.
Key facts on Straumann stock
- Company: Straumann Holding AG
- ISIN: CH0012280076
- Ticker: STMN
- Venue: SIX Swiss Exchange
- Sector / Industry: Health Care / Medical Technology, Dental
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
